Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of...
363 insider purchases on record · latest filing 2026-03-19.
Insiders have also filed 636 sale transactions at CORT.